Previous close | 288.06 |
Open | 286.92 |
Bid | 296.86 x 100 |
Ask | 297.12 x 100 |
Day's range | 285.27 - 297.70 |
52-week range | 208.62 - 297.70 |
Volume | |
Avg. volume | 545,834 |
Market cap | 13.18B |
Beta (5Y monthly) | 0.49 |
PE ratio (TTM) | 14.07 |
EPS (TTM) | 21.12 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 302.87 |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
On June 13, 2024, Director Christopher Causey sold 2,000 shares of United Therapeutics Corp (NASDAQ:UTHR) as reported in a recent SEC Filing.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.